SEC Comment Letter for DLP Positive Note Fund LLC (CIK 0001806014) — Jun 2, 2020
DLP Positive Note Fund LLC (CIK 0001806014)
Date: June 2, 2020 · CIK: 0001806014 · Accession: 0000000000-20-004930
AI Filing Summary & Sentiment
File numbers found in text: 024-11180
Show Raw Text
United States securities and exchange commission logo
June 2, 2020
Donald Wenner
President, DLP PNF Manager LLC
DLP Positive Note Fund LLC
605 Palencia Club Drive
St. Augustine, FL 32095
Re:DLP Positive Note Fund LLC
Amendment No. 2 to Form 1-A
Filed May 22, 2020
File No. 024-11180
Dear Mr. Wenner:
We have reviewed your amended offering statement and have the following
comments. In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
Please respond to this letter by amending your offering statement and providing the
requested information. If you do not believe our comments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your offering statement and the information you
provide in response to these comments, we may have additional comments. Unless we note
otherwise, our references to prior comments are to comments in our April 9, 2020 letter.
Amendment No. 2 to Form 1-A
Description of Securities Offered, page 37
1.We reissue prior comment 1 to the extent it applies to waiver of jury trial set forth in
section 6.02(b) of the Limited Liability Company Operating Agreement. Please describe
this provision in your offering circular. Also disclose:
•Whether this provision applies to federal securities law claims;
•Whether this provision applies to other applicable state or federal law claims;
•Whether secondary purchasers would be subject to this provision;
FirstName LastNameDonald Wenner
Comapany NameDLP Positive Note Fund LLC
June 2, 2020 Page 2
FirstName LastNameDonald Wenner
DLP Positive Note Fund LLC
June 2, 2020
Page 2
•If you plan to apply this provision to federal securities law claims, that investors
cannot waive compliance with the federal securities laws and the rules and
regulations promulgated thereunder (see Section 14 of the Securities Act and Section
29(a) of the Exchange Act);
•If applicable, risk factors relating to this provision; and
•If applicable, uncertainty regarding whether courts would enforce this provision.
If this provision does not apply to federal securities law claims, please revise your exhibit
to clarify.
Prior Performance Summary
Table I, page 42
2.We note that you have included an overview of DLP Income & Growth Fund I, LLC
twice and no overview has been included for DLP Fixed Fund I, LLC. Please revise as
appropriate.
3.We note your response to prior comment 4 and the revised disclosure on page 42. We note
that the dollar amount offered in prior Program A (DLP Lending Fund, LLC) and prior
Program C (DLP Income & Growth Fund I, LLC) is inconsistent with the overview on
pages 40 and 41. Please revise to correct these discrepancies.
Table III, page 44
4.We note your response to prior comment 5 and the revised disclosure on pages 44 and 45.
We note that you have disclosed the total dollar amount of distributions paid for each
program. Please further revise Table III to disclose the dollar amount of distributions per
$1,000 investment.
Note Schedule, page 63
5.We note your response to prior comment 9. It appears you are proposing to offer
additional securities with terms that differ from those set forth in the Note Schedule.
Please revise the disclosure throughout the filing to delete the "periodic change" of the
interest rates and maturity dates or advise. Also clarify throughout the filing the maturity
dates of the notes. For example, the Note Schedule reflects three different maturity dates
but your disclosure elsewhere indicates that there may be additional maturity dates. For
the open redemption notes, please indicate the final maturity dates. Also revise your
disclosure throughout the filing to clarify that you are only offering up to $50 million in
notes and state the termination date of the offering. See Rule 251(d)(3)(i)(F).
FirstName LastNameDonald Wenner
Comapany NameDLP Positive Note Fund LLC
June 2, 2020 Page 3
FirstName LastName
Donald Wenner
DLP Positive Note Fund LLC
June 2, 2020
Page 3
You may contact Jorge Bonilla at 202-551-3414 or Kristina Marrone at 202-551-3429 if
you have questions regarding comments on the financial statements and related matters. Please
contact Ruairi Regan at 202-551-3269 or Brigitte Lippmann at 202-551-3713 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Real Estate & Construction
cc: Ira Levine, Esq.